Cell Processing News Today

Fourth quarter Cell Processing revenue increased 11% sequentially to $14.8 million BOTHELL, Wash., Jan. 8, 2024 /PRNewswire/ -- BioLife Solutions, Inc.  , a leading developer and supplier of...

OrganaBio, the Contract Technology Development and Manufacturing Organization (CTDMO) specializing in solutions for cell and immunotherapy development, today announces the official launch of Cell Processing and Cryopreservation (CPC) Services, a new division of OrganaBio.

OrganaBio, a contract technology development and manufacturing organization (CTDMO) specializing in solutions for cell and immunotherapy development, has launched a new division.

/PRNewswire/ -- The "Cell Therapy Technologies Market by Product (Media, Sera & Reagents, Cell Culture Vessels, Single-Use Equipment), Process (Cell...

Operator: Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to the BioLife Solutions Second Quarter 2023 Shareholders and Analyst Conference Call.

Operator: Hello. My name is Mallory, and I will be your conference operator today. At this time, I would like to welcome everyone to the Q1 2023 BioLife Solutions, Inc. Earnings Conference Call.

From development to distribution, Interphex 2023 (April 25-27 New York, US) takes you through the entire pharma product lifecycle.

The Business Research Companys Biotechnology Services Global Market Report 2023 – Market Size, Trends, And Global Forecast 2023-2032

Operator: Good day, and welcome to the BioLife Solutions Fourth Quarter 2022 and Full Year Earnings Call. Todays call is being recorded.

The MHRA’s UK Stem Cell Bank is one of only two places in the world to test this technology.